Risk-based quality management (RBQM) aims to detect the right signals early enough to prevent an issue from occurring. To ...
In today’s ACT Brief, we examine why outdated views of Asia Pacific trial sites persist, how community access gaps reflect ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how FDA ...
ACT Brief: Capturing Trial Friction, AI Matching Model Comparisons, and Boehringer’s Oncology Deal
In today’s ACT Brief, we examine how capturing friction in real time can reveal site burden, how OpenAI and Mistral compare ...
In this video interview, James Cheong, senior vice president of Asia Pacific at Precision for Medicine, explains how regulatory reform and inspection data contradict the view that APAC sites are ...
The planned sites in Livonia, Las Vegas, and San Antonio would expand a partnership that places clinical research and health ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, describes how manual eligibility screening and swivel-chair ...
In this Q&A, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, discusses ...
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
Applied Clinical Trials is the thought leader in pharmaceutical drug development operations and clinical trial design, management, and monitoring.
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement ...
In this video interview, Kent Thoelke, CEO of Paradigm Health, explains why patient cost barriers and site infrastructure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results